Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 82.75% institutional investors, 6.20% insiders, and 11.05% retail investors. Blackrock is the largest institutional shareholder, holding 16.01% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.57% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 82.75% | 6.20% | 11.05% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 18.69M | 16.01% | $289.58M |
| Blackrock funding, inc. /de | 18.90M | 15.47% | $410.14M |
| Vanguard group | 8.43M | 7.09% | $175.96M |
| State street | 5.80M | 4.87% | $120.97M |
| Dimensional fund advisors lp | 3.01M | 2.53% | $62.88M |
| Deerfield management company, l.p. (series c) | 2.88M | 2.36% | $62.48M |
| Goldman sachs group | 2.80M | 2.36% | $58.49M |
| Renaissance | 2.71M | 2.28% | $56.48M |
| Geode capital management | 2.67M | 2.24% | $55.64M |
| Fundsmith llp | 2.71M | 2.22% | $58.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tanaka capital management | 153.29K | 7.31% | $3.20M |
| Gables capital management | 409.02K | 4.20% | $8.88M |
| Jw asset management | 388.39K | 4.15% | $8.43M |
| Knott david m jr | 176.00K | 1.73% | $3.82M |
| Qsv equity investors | 53.44K | 1.21% | $1.16M |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Deerfield management company, l.p. (series c) | 2.88M | 1.13% | $62.48M |
| Ikarian capital | 209.65K | 0.87% | $4.55M |
| Hussman strategic advisors | 147.00K | 0.73% | $3.19M |
| Pvg asset management | 11.79K | 0.72% | $182.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 2.80M | 0.01% | 1.33M |
| American century companies | 1.76M | 0.02% | 1.23M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| Macquarie group | 682.65K | 0.02% | 682.65K |
| Fundsmith llp | 2.71M | 0.26% | 557.81K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 1.01M | 0.00% | -786.18K |
| Point72 asset management | - | - | -618.30K |
| Deerfield management company, l.p. (series c) | 2.88M | 1.13% | -542.67K |
| Brandywine global investment management | - | - | -392.12K |
| Deutsche bank ag\ | 200.40K | 0.00% | -377.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Macquarie group | 682.65K | 0.02% | 682.65K | $14.25M |
| Orbimed advisors | 416.90K | 0.23% | 416.90K | $9.05M |
| Wedge capital management l l p/nc | 145.17K | 0.05% | 145.17K | $2.86M |
| Norges bank | 91.77K | 0.00% | 91.77K | $1.92M |
| Glenmede investment management, lp | 77.14K | 0.01% | 77.14K | $1.67M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Coppell advisory solutions | -8.00 |
| Mendota financial group | -12.00 |
| Richards, merrill & peterson | -15.00 |
| Aspire private capital | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 354 | -3.54% | 101,094,756 | 3.01% | 82 | 1.27% | 204 | 3.55% | 118 | -2.48% |
| Mar 31, 2025 | 361 | 6.80% | 97,419,101 | -0.16% | 80 | 1.19% | 193 | -4.46% | 119 | 33.71% |
| Dec 31, 2024 | 329 | 4.44% | 99,023,975 | 3.92% | 83 | 1.30% | 195 | 21.88% | 87 | -17.14% |
| Sep 30, 2024 | 313 | 14.65% | 95,228,606 | -1.82% | 80 | 1.16% | 159 | 25.20% | 104 | 18.18% |
| Jun 30, 2024 | 270 | - | 96,978,188 | 0.88% | 83 | 1.02% | 126 | -20.75% | 87 | 26.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.82M | 5.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.63M | 2.97% | -77.47K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| iShares Russell 2000 ETF | 2.78M | 2.27% | - |
| Smithson Investment Trust Ord | 2.71M | 2.21% | - |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| Avantis US Small Cap Value ETF | 1.80M | 1.47% | 14.54K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.23M | 1.01% | -534.49K |
| SPDR® S&P Biotech ETF | 1.17M | 0.95% | 2.60K |
| Fidelity Small Cap Index | 1.16M | 0.95% | 15.51K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $609.00K |
| Sep 04, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $585.60K |
| Sep 03, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $401.60K |
| Aug 27, 2025 | Tierney David S | - | Sell | $525.20K |
| Aug 26, 2025 | Miller Steve | Chief Op. & Scientific Officer | Sell | $2.33M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 14 |
| 2024 Q3 | - | 7 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools